See below...So it looks like they had $6.4mm in cash at the end of 2010 and have since received $4mm. Given their quarterly burn of ~ $2mm, that puts them at roughly $8mm - i.e. enough for another year. I would think they would at least wait until after the trial results to do another raise.
“We ended 2010 with $6.4 million in cash,” Larson continued, and since that time we have received over $4 million in funds from the exercise of issued warrants. Our cash position is stronger than it has been in recent years, which we believe provides the ability to fund our current drug development initiatives.”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.